0

Endocrine Cancer Collection
 1-20 of 158 Articles
Original Research |  3 September 2013
A Prospective Assessment Defining the Limitations of Thyroid Nodule Pathologic Evaluation
Edmund S. Cibas, MD; Zubair W. Baloch, MD, PhD; Giovanni Fellegara, MD; et al.
Ann Intern Med. 2013;159(5):325-332. doi:10.7326/0003-4819-159-5-201309030-00006
Editorials |  1 September 2009
Primary Aldosteronism—One Picture Is Not Worth a Thousand Words
William F. Young, MD, MSc
Ann Intern Med. 2009;151(5):357-358. doi:10.7326/0003-4819-151-5-200909010-00013
Reviews |  1 September 2009
Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism
Marlies J.E. Kempers, MD, PhD; Jacques W.M. Lenders, MD, PhD; Lieke van Outheusden, MSc; et al.
Ann Intern Med. 2009;151(5):329-337. doi:10.7326/0003-4819-151-5-200909010-00007
Articles |  6 January 2009 FREE
Brief Communication: Radiographic Contrast Infusion and Catecholamine Release in Patients With Pheochromocytoma
Smita K. Baid, MD; Edwin W. Lai, BS; Robert A. Wesley, PhD; et al.
Ann Intern Med. 2009;150(1):27-32. doi:10.7326/0003-4819-150-1-200901060-00006
Reviews |  7 June 2005
Continuing Controversies in the Management of Thyroid Nodules
M. Regina Castro, MD; Hossein Gharib, MD
Ann Intern Med. 2005;142(11):926-931. doi:10.7326/0003-4819-142-11-200506070-00011
Brief Communications |  18 February 2003
Natural History of Benign Solid and Cystic Thyroid Nodules
Erik K. Alexander, MD; Shelley Hurwitz, PhD; Jenny P. Heering, BA; et al.
Ann Intern Med. 2003;138(4):315-318. doi:10.7326/0003-4819-138-4-200302180-00010
Brief Communications |  21 August 2001
Primary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery
Anna M. Sawka, MD; William F. Young, MD; Geoffrey B. Thompson, MD; et al.
Ann Intern Med. 2001;135(4):258-261. doi:10.7326/0003-4819-135-4-200108210-00010
Articles |  15 October 1998
Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma
Terry Taylor, MD; Bonny Specker, PhD; Jacob Robbins, MD; et al.
Ann Intern Med. 1998;129(8):622-627. doi:10.7326/0003-4819-129-8-199810150-00007
Editorials |  1 March 1998
Medical Treatment of Benign Thyroid Nodules: Have We Defined a Benefit?
E. Chester Ridgway, MD
Ann Intern Med. 1998;128(5):403-405. doi:10.7326/0003-4819-128-5-199803010-00010
Editorials |  15 August 1996
Plasma or Urinary Metanephrines for the Diagnosis of Pheochromocytoma? That Is the Question
Emmanuel L. Bravo, MD
Ann Intern Med. 1996;125(4):331-332. doi:10.7326/0003-4819-125-4-199608150-00012
Brief Communications |  15 August 1996
The Urinary Metanephrine-to-Creatinine Ratio for the Diagnosis of Pheochromocytoma
Emmanuel Heron, MD; Gilles Chatellier, MD; Eliane Billaud, PhD; et al.
Ann Intern Med. 1996;125(4):300-303. doi:10.7326/0003-4819-125-4-199608150-00008
Articles |  1 July 1996
Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of Other Imaging Methods in Detecting Primary and Metastatic Gastrinomas: A Prospective Study
Fathia Gibril, MD; James C. Reynolds, MD; John L. Doppman, MD; et al.
Ann Intern Med. 1996;125(1):26-34. doi:10.7326/0003-4819-125-1-199607010-00005
Editorials |  15 July 1995
Searching for Pheochromocytoma: A New and Better Test?
Lawrence R. Krakoff, MD
Ann Intern Med. 1995;123(2):150-151. doi:10.7326/0003-4819-123-2-199507150-00011
Articles |  15 July 1995
Plasma Metanephrines in the Diagnosis of Pheochromocytoma
Jacques W. M. Lenders; Harry R. Keiser; David S. Goldstein; et al.
Ann Intern Med. 1995;123(2):101-109. doi:10.7326/0003-4819-123-2-199507150-00004
Diagnosis and Treatment |  15 January 1995
Genetic Testing in the Diagnosis and Management of Multiple Endocrine Neoplasia Type II
Gregory A. Ledger, MD; Sundeep Khosla, MD; Noralane M. Lindor, MD; et al.
Ann Intern Med. 1995;122(2):118-124. doi:10.7326/0003-4819-122-2-199501150-00008
Editorials |  1 January 1995
Why Do Clinicians Continue to Debate the Use of Levothyroxine in the Diagnosis and Management of Thyroid Nodules?
Manfred Blum, MD
Ann Intern Med. 1995;122(1):63-64. doi:10.7326/0003-4819-122-1-199501010-00011
Reviews |  1 December 1994
Diagnosis and Treatment of Primary Hyperaldosteronism
Jon D. Blumenfeld, MD; Jean E. Sealey, ScD; Yvette Schlussel, PhD; et al.
Ann Intern Med. 1994;121(11):877-885. doi:10.7326/0003-4819-121-11-199412010-00010
Editorials |  1 August 1994
Omeprazole, Hypergastrinemia, and Gastric Carcinoid Tumors
James W. Freston, MD, PhD
Ann Intern Med. 1994;121(3):232-233. doi:10.7326/0003-4819-121-3-199408010-00012
Brief Reports |  15 March 1994
Silent Adrenal Nodules in von Hippel-Lindau Disease Suggest Pheochromocytoma
Brian S. Aprill, MD; Almond J. Drake, MD; David H. Lasseter, MD; et al.
Ann Intern Med. 1994;120(6):485-487. doi:10.7326/0003-4819-120-6-199403150-00006
Articles |  1 August 1993
Assessment and Prediction of Long-term Cure in Patients with the Zollinger-Ellison Syndrome: The Best Approach
Vitaly A. Fishbeyn, MD; Jeffrey A. Norton, MD; Richard V. Benya, MD; et al.
Ann Intern Med. 1993;119(3):199-206. doi:10.7326/0003-4819-119-3-199308010-00004
Advertisement

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)